Skip to main content
Start of content

House Publications

The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Notice Paper

No. 185

Wednesday, April 26, 2023

2:00 p.m.


Introduction of Government Bills

Introduction of Private Members' Bills

April 25, 2023 — Mrs. Romanado (Longueuil—Charles-LeMoyne) — Bill entitled “An Act to establish a national day to honour Canadian women’s contributions to science, technology, engineering and mathematics”.

April 25, 2023 — Mrs. Zahid (Scarborough Centre) — Bill entitled “An Act to amend the Canadian Security Intelligence Service Act (duty of candour)”.

Notices of Motions (Routine Proceedings)

April 25, 2023 — Mrs. Gallant (Renfrew—Nipissing—Pembroke) — That the third report of the Standing Committee on National Defence, presented on Monday, April 24, 2023, be concurred in.

April 25, 2023 — Mr. Bragdon (Tobique—Mactaquac) — That the 10th report of the Standing Committee on Fisheries and Oceans, presented on Tuesday, April 18, 2023, be concurred in.

April 25, 2023 — Mr. Kelly (Calgary Rocky Ridge) — That the third report of the Standing Committee on National Defence, presented on Monday, April 24, 2023, be concurred in.

Questions

Q-14462 — April 25, 2023 — Mr. Melillo (Kenora) — With regard to government subsidies for Volkswagen (VW) and the announcement in St. Thomas: (a) when was the timeline of decisions related to VW made and when were the offers sent or received; (b) did the government consider alternative companies to receive subsidies, and, if so, what (i) expressions of interest were received from other companies in this regard, (ii) monetary and non-monetary demands were received in each expression of interest; (c) what were the decision-making factors that the government weighed when making the VW commitment; (d) what additional non-monetary commitments were made to VW; and (e) has the government imposed any conditions on VW in relation to the sourcing of critical minerals and other raw materials from within Canada, and, if so, what are the conditions?
Q-14472 — April 25, 2023 — Mrs. Block (Carlton Trail—Eagle Creek) — With regard to the COVID-19 vaccine doses procured by the government: (a) how many doses purchased are known to have (i) been lost or stolen, (ii) expired, broken down by manufacturer; and (b) what are the details of each instance where doses were lost or stolen, including, for each, the (i) date, (ii) number of doses, (iii) manufacturer, (iv) location, (v) incident summary?
Q-14482 — April 25, 2023 — Mr. Carrie (Oshawa) — With regard to the Public Health Agency of Canada (PHAC) and Health Canada (HC): (a) did PHAC or HC receive or become aware of documents related to Pfizer-BioNTech which were the subject of a court order requiring their release to the public starting around January 6, 2022; (b) if the answer to (a) is affirmative, (i) when did the government receive them, (ii) which department or agency reviewed them, (iii) what conclusions and recommendations were arrived at, (iv) was a risk versus benefit analysis conducted after the review, and, if so, what were the findings, (v) when did the review commence and finish; (c) did PHAC or HC receive or become aware of the document titled: “5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021”, and, if so, (i) on what date did PHAC or HC review the document, (ii) what were the conclusions and recommendations that resulted from the review of the document, (iii) when did the review commence and finish, (iv) which Canadian federal health agency was assigned to review this document and when; (d) what are PHAC’s and HC’s latest warnings or instructions to health care professionals who advise Canadians about the Pfizer-BioNTech COVID-19 vaccine; (e) do the warnings or instructions in (d) consider the adverse events of special interest identified in the Pfizer study; and (f) will the government notify Canadians about the events in (d)?
Q-14492 — April 25, 2023 — Mr. Mazier (Dauphin—Swan River—Neepawa) — With regard to the Centre for Rural Economic Development: (a) where is the Centre for Rural Economic Development headquartered; (b) how many full time equivalents are employed by the Centre for Rural Economic Development; (c) what are the classifications and job titles of each employee in (b); (d) how many rural communities have contacted the Centre for Rural Economic Development, broken down by community and fiscal year; (e) how many issues raised with the Centre for Rural Economic Development were deemed (i) resolved, (ii) unresolved; (f) what was the total annual budget and the forecasted budget for each fiscal year between 2019-20 and 2025-26; (g) what is the annual spending, broken down by year and by standard object, from 2019-20 to 2022-23; (h) what is the amount of spending on internal services or overhead, broken down by year, between 2019-20 and 2022-23; and (i) what are the latest performance indicators and results?
Q-14502 — April 25, 2023 — Mr. Mazier (Dauphin—Swan River—Neepawa) — With regard to the connectivity (i.e. internet, cellular, broadband, etc.) funding announced by the government since November 4, 2015, broken down by company: (a) what is the total amount of money announced to date for Bell Canada, Telus Communications Inc., Rogers Communications Inc. and their subsidiaries, for connectivity under the (i) CRTC Broadband Fund, (ii) Strategic Innovation Fund, (iii) Universal Broadband Fund, (iv) Connect to Innovate program, (v) First Nation Infrastructure Fund, (vi) Canada Infrastructure Bank, (vii) Investing in Canada Plan; and (b) of the amounts in each subsection in (a), how much has been transferred?
Q-14512 — April 25, 2023 — Mr. Mazier (Dauphin—Swan River—Neepawa) — With regard to government funding for satellite internet service companies, since November 4, 2015: (a) what is the total amount of money that has been (i) announced for, (ii) transferred, to Kepler Communications Inc. or its subsidiaries, broken down by program; (b) what are the details of each funding announcement or transfer in (a), including the (i) date of the announcement, (ii) amount announced, (iii) project description, including the location, (iv) program, (v) date the funding was transferred, (vi) amount of the transfer; (c) what is the total amount of money that has been (i) announced for, (ii) transferred, to Starlink and its parent company Space Exploration Technologies Corporation (SpaceX), or any subsidiaries, broken down by program; and (d) what are the details of each funding announcement or transfer in (c), including the (i) date of the announcement, (ii) amount announced, (iii) project description, including the location, (iv) program, (v) date the funding was transferred, (vi) amount of the transfer?

Notices of Motions for the Production of Papers

Business of Supply

Government Business

Private Members' Notices of Motions

Private Members' Business

S-211 — March 6, 2023 — Resuming consideration of the motion of Mr. McKay (Scarborough—Guildwood), seconded by Mr. Zuberi (Pierrefonds—Dollard), — That Bill S-211, An Act to enact the Fighting Against Forced Labour and Child Labour in Supply Chains Act and to amend the Customs Tariff, be now read a third time and do pass.
Pursuant to Standing Order 86(3), jointly seconded by:
Mr. Viersen (Peace River—Westlock) — May 5, 2022
Mr. Morrice (Kitchener Centre) — May 16, 2022
Debate — one hour remaining, pursuant to Standing Order 98(2).
Voting — at the expiry of the time provided for debate, pursuant to Standing Order 98(4).

2 Response requested within 45 days